Utility of the Pharmacogenetic Information Provided by NEUROPHARMAGEN in the Treatment of Bipolar Depressionwith Bipolar Depression

NCT04923204 · clinicaltrials.gov ↗

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder

Interventions

DIAGNOSTIC_TEST: Pharmacogenomic-testing with NEUROPHARMAGEN

Sponsor

AB Biotics, SA

Collaborators

[object Object]